Bridgeway Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$593K Hold
125,700
0.01% 744
2025
Q1
$577K Sell
125,700
-40,500
-24% -$186K 0.01% 720
2024
Q4
$796K Sell
166,200
-253,287
-60% -$1.21M 0.02% 714
2024
Q3
$1.97M Sell
419,487
-18,476
-4% -$86.7K 0.04% 524
2024
Q2
$2.47M Sell
437,963
-88,420
-17% -$500K 0.06% 445
2024
Q1
$2.16M Buy
526,383
+165,215
+46% +$679K 0.04% 556
2023
Q4
$1.52M Sell
361,168
-271,911
-43% -$1.15M 0.03% 662
2023
Q3
$2.73M Sell
633,079
-100,996
-14% -$436K 0.07% 444
2023
Q2
$4.84M Buy
734,075
+45,738
+7% +$301K 0.12% 289
2023
Q1
$4.67M Buy
688,337
+362,737
+111% +$2.46M 0.12% 276
2022
Q4
$2.41M Buy
+325,600
New +$2.41M 0.06% 496
2022
Q1
Sell
-160,300
Closed -$2.52M 1358
2021
Q4
$2.52M Buy
160,300
+17,700
+12% +$278K 0.05% 539
2021
Q3
$2.44M Hold
142,600
0.05% 544
2021
Q2
$3.07M Buy
+142,600
New +$3.07M 0.05% 463
2016
Q4
Sell
-35,000
Closed -$582K 1467
2016
Q3
$582K Hold
35,000
0.01% 1021
2016
Q2
$392K Hold
35,000
0.01% 1148
2016
Q1
$293K Sell
35,000
-24,300
-41% -$203K ﹤0.01% 1220
2015
Q4
$552K Hold
59,300
0.01% 1023
2015
Q3
$669K Hold
59,300
0.01% 897
2015
Q2
$753K Sell
59,300
-20,000
-25% -$254K 0.01% 894
2015
Q1
$737K Sell
79,300
-700
-0.9% -$6.51K 0.02% 920
2014
Q4
$1.15M Hold
80,000
0.03% 721
2014
Q3
$830K Hold
80,000
0.02% 833
2014
Q2
$1.29M Sell
80,000
-134,792
-63% -$2.18M 0.03% 672
2014
Q1
$3.49M Sell
214,792
-33,308
-13% -$541K 0.1% 259
2013
Q4
$3.08M Hold
248,100
0.09% 291
2013
Q3
$2.72M Sell
248,100
-1,000
-0.4% -$11K 0.09% 283
2013
Q2
$2.01M Buy
+249,100
New +$2.01M 0.08% 329